THE TURQUALITY ERA IN SANTA FARMA’S GLOBAL BRAND JOURNEY

Santa Farma, one of Türkiye’s long-established pharmaceutical companies, has crossed another significant milestone in its journey toward international growth by joining the TURQUALITY Support Program administered by the Turkish Ministry of Trade. With over 80 years of experience, the company aims to further strengthen its brand position in global markets through this development. Since its inception, Santa Farma has continued its operations with the philosophy of “providing healthy services for health.” With its robust production infrastructure, R&D investments, and high-quality standards, the company continues to develop its vision for sustainable growth not only in Türkiye but also in international markets. Its acceptance into the TURQUALITY program stands out as a key indicator of the company’s branding, corporate transformation, and globalization strategy.

In this context, Santa Farma is advancing its efforts on a five-year “Development Roadmap” that spans from organizational structure to human resources, and from digital transformation to brand management. The company is also redefining its vision, centering on the goal of becoming a benchmark company that bridges local needs in the healthcare sector with global standards. This approach is shaped by selective growth, innovation, product-market fit, and a people-centric corporate culture. Commenting on the matter, Santa Farma CEO Sami Kiresepi noted that the TURQUALITY process holds strategic importance for the company’s long-term transformation vision, stating:

“The Development Roadmap we will prepare serves as a strategic compass outlining how Santa Farma will become a benchmark company in the future. Our inclusion in the TURQUALITY Support Program is a significant reflection of the transformation process we have been steadfastly pursuing for many years. With the contributions of this program, we aim to position our production capacity and expertise in the healthcare sector more effectively in international markets.”

Over the past two years, Santa Farma has pursued a growth strategy focused on greater visibility in international markets; while initiating new licensing processes in Europe, the Gulf region, Latin America, and the Far East, the company has also taken significant steps in the areas of hybrid licensing and technology partnerships. The company aims to further advance the growth it has achieved in exports with the strategic support provided by TURQUALITY.

Operating from its 80,000 – square – meter production complex in Dilovası and with an R&D infrastructure compliant with global GxP standards, Santa Farma is pursuing a strategy focused on long-term and sustainable growth in selected markets. The company aims to make a strong pharmaceutical brand originating from Türkiye more visible on an international scale through its quality-focused production philosophy, innovation investments, and robust corporate structure.